NEW YORK, March 03, 2016 -- EXL (NASDAQ:EXLS), a leading provider of Operations Management and Analytics services, today announced the appointment of Patrick Rice as Senior Vice President, Business Development for EXL Healthcare. Rice is a 20-year industry veteran and most recently Managing Director and overall Sales Lead for Accenture’s North American Health and Public Services Group.
“Patrick Rice has demonstrated the ability to build multi-tower transformational client relationships within the healthcare industry, and I am excited to have him join our rapidly growing practice,” said Rembert de Villa, Executive Vice President and Head of EXL Healthcare. “Healthcare is a strategic priority at EXL, and Patrick combines industry expertise with the ability to implement effective go-to-market approaches and to scale sales operations.”
Rice also held the roles of Sales Lead for Accenture’s North American Provider Portfolio and for large, complex sales in the healthcare, pharmaceutical and manufacturing markets. Previously, Rice was Senior Director for Business Development at Convergys, where he led the team that won what was at the time one of the largest contracts in the business process outsourcing (BPO) industry. Throughout his leadership roles, Rice has exceled at optimizing the sales process and building solution teams that support clients in improving results through operational excellence. Rice holds a BA in Economics from Cortland State University.
“This is a great time to be joining EXL Healthcare,” Rice said. “I was attracted to the EXL’s focus, growth, deep talent and integrated capabilities. The disruption occurring in the healthcare industry has created opportunities for new innovative approaches to support payers’ and providers’ goals of increasing quality while reducing the cost of care. I look forward to helping EXL scale its already strong footprint in this industry.”
EXL Healthcare delivers strategic solutions that integrate operations management, analytics, technology and consulting in the areas of population health management, revenue cycle management, payment integrity, customer experience, and revenue optimization. EXL Healthcare was named to the “Winner’s Circle” in both the “HfS Blueprint Report: Healthcare Payer Operations 2015” and the “HfS Blueprint Report: 2015 Population Health and Care Management Business Services.”
About EXL
EXL (NASDAQ:EXLS) is a leading operations management and analytics company that helps businesses enhance growth and profitability in the face of relentless competition and continuous disruption. Using our proprietary award-winning Business EXLerator Framework™, which integrate analytics, automation, benchmarking, BPO, consulting, industry best practices and technology platforms to look deeper to help companies improve global operations, enhance data-driven insights, increase customer satisfaction, and manage risk and compliance. EXL serves the insurance, healthcare, banking and financial services, utilities, travel, transportation and logistics industries. Headquartered in New York, New York, EXL has more than 24,000 professionals in locations throughout the United States, Europe, Asia (primarily India and Philippines), Latin America, Australia and South Africa. For more information, visit www.exlservice.com.
Media contact: Michael Sherrill Vice President, Marketing [email protected] 646-419-0778


Instagram Outage Disrupts Thousands of U.S. Users
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 



